Products
- Anti-Obesity Compound Library
- GPCR/G Protein-Targeted Compounds
- Immunology/Inflammation-Targeted Compounds
- JAK/STAT-Targeted Compounds
- MAPK-Targeted Compounds
- Membrane Transporter/Ion Channel-Targeted Compounds
- Metabolism-Targeted Compounds
- NF-κB-Targeted Compounds
- Microbiology/Virology-Targeted Compounds
- Neuronal Signaling-Targeted Compounds
- Oxidation-reduction-Targeted Compounds
- PI3K/Akt/mTOR-Targeted Compounds
- Proteases/Proteasome-Targeted Compounds
- Stem Cells/Wnt-Targeted Compounds
- Tyrosine Kinase/Adaptors-Targeted Compounds
- Ubiquitin-Targeted Compounds
Online Inquiry
Fexofenadine hydrochloride
Cat. No.:
OB0225LY-0125
Appearance:
Solid
Purity:
≥99%
Identity:
Confirmed by NMR and LC-MS.
Size:
Product Overview
Description:
Fexofenadine hydrochloride is a long-lasting selective histamine H1 receptor antagonist, with antihistaminic activity.
Synonym:
138452-21-8; Fexofenadine; 2-(4-(1-Hydroxy-4-(4-(hydroxydiphenylmethyl)piperidin-1-yl)butyl)phenyl)-2-methylpropanoic acid; 4-(1-Hydroxy-4-(4-(hydroxydiphenylmethyl)-1-piperidinyl)butyl)-alpha,alpha-dimethylbenzeneacetic acid; 2-[4-[1-Hydroxy-4-[4-[hydroxy(diphenyl)methyl]piperidin-1-yl]butyl]phenyl]-2-methylpropanoic acid
CAS No.:
138452-21-8
Compound CID:
3348
Formula:
C32H40ClNO4
Formula Weight:
538.12
Specification
Stability:
3 years in powder form.
Storage:
Storage at -20°C.
Applications:
Fexofenadine hydrochloride plays an important role in the study of seasonal allergic rhinitis and chronic urticaria without significant side effects.
Library Information
Targets:
Histamine receptor
Receptors:
H1 receptor
Pathways:
Immunology/Inflammation; GPCR/G protein; Neuronal signaling
Plate Number:
AOCL-2
Plate Location:
e8
Empty Location:
a1-h1; a12-h12
Container:
96-well plate
Formulation:
10 mM DMSO
DMSO Max Solubility:
55 mg/mL; 102.21 mM
